The combination of strong operational performance, optimistic guidance, and resolution of a major litigation overhang presents a compelling investment case. The stock may re-rate higher on improved sentiment, though investors should monitor Medicaid reimbursement risks mentioned in the forward-looking statements.
Price Chart
Executive Summary
Universal Health Services reported strong 2025 financial results with 9.7% revenue growth and a 37.3% increase in adjusted EPS to $21.74, driven by volume and pricing improvements across both acute and behavioral health segments. The company also announced a favorable court ruling vacating a $500 million punitive damages verdict, though it maintains an $18 million reserve for the matter. Management provided optimistic 2026 guidance, forecasting 7.1% revenue growth and 8.5% adjusted EPS growth.
Key Financial Metrics
Key Facts
- 2025 revenue grew 9.7% to $17.365 billion; adjusted EPS increased 30.9% to $21.74
- 2026 guidance calls for $18.417-$18.789 billion revenue (7.1% midpoint growth) and $22.64-$24.52 EPS (8.5% midpoint growth)
- Nevada court vacated $500 million punitive damages verdict, though $18 million legal reserve remains
- Behavioral health same-facility revenue grew 7.7%, acute care grew 8.5% in 2025
- Company repurchased $899.3 million of stock in 2025 with $1.425 billion remaining authorization
Financial Impact
2025 revenue $17.365 billion (+9.7% YoY), adjusted EPS $21.74 (+30.9% YoY); 2026 revenue guidance $18.6 billion midpoint (+7.1% YoY), EPS guidance $23.58 midpoint (+8.5% YoY)
Segment Breakdown
| Segment | Revenue | Growth |
|---|---|---|
| Acute Care | $9.9B | +8.5% |
| Behavioral Health | $7.4B | +8.0% |
Risk Factors
- Potential reinstatement of punitive damages on appeal (though capped at $14 million under Nevada law)
- Legislative changes limiting Medicaid enrollment and provider fees could impact future revenues
- Interest rate increases have adversely impacted free cash flow
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-073545 |
| Document: uhs-20260225.htm | 0001193125-26-073545 |
| Document: 0001193125-26-073545-index-headers.html | 0001193125-26-073545 |
| Document: 0001193125-26-073545-index.html | 0001193125-26-073545 |
| Document: 0001193125-26-073545.txt | 0001193125-26-073545 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 21, 2026 6w ago | 8-K | $177.26 $176.69 | ▼ −0.32% | ▼ −0.04% | $174.49 (−1.57%) |
Jul 27, 2026 9w ago | Press Release | $166.22 $175.66 | ▼ −5.68% | ▼ −2.30% | $174.49 (−4.97%) |
May 21, 2026 19w ago | 8-K | $162.28 $141.17 | ▼ −13.01% | ▼ −13.55% | $174.49 (+7.52%) |
Apr 24, 2026 23w ago | 8-K | $173.78 $162.45 | ▼ −6.52% | ▼ −10.55% | $174.49 (+0.41%) |
Apr 9, 2026 25w ago | DEFA14A | $187.57 $168.49 | ▼ −10.17% | ▼ −17.74% | $174.49 (−6.98%) |
Feb 26, 2026 31w ago | 8-K | $203.26 $185.07 | ▼ −8.95% | ▼ −2.55% | $174.49 (−14.16%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access